Fig. 1From: Disease–treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissueMechanisms by which metabolic disorders may simultaneously cause atrial and ventricular myopathy, leading to atrial fibrillation and to heart failure with a preserved ejection fractionBack to article page